XNCR Q1 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+4.9% YoY

Gross Profit

-$7M-21.9% margin

Operating Income

-$16M-46.1% margin

Net Income

-$2M-7.3% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-18.8%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$693M

Total Liabilities

$109M

Stockholders' Equity

$584M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$32M	+4.9%
Gross Profit	-$7M	-$2M	-377.9%
Operating Income	-$16M	-$9M	-78.6%
Net Income	-$2M	-$8M	+69.2%

Revenue Segments

Collaboration

$15M44%

Milestone

$13M37%

Royalty

$7M20%